Beam Therapeutics Inc.（BEAM）价格预测BEAMBeam Therapeutics Inc.

Alphio's BEAM stock price prediction model matches the current Beam Therapeutics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.87 (+0.32%). The 1-week path is $23.84 (+0.19%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Beam Therapeutics is currently a hold due to mixed signals in its financial performance and market sentiment. The stock is priced at $24.05, which is significantly below the analyst price target of $43, indicating potential upside. However, the RSI is at 42.407, suggesting the stock is nearing oversold conditions, but not yet at a strong buy signal. Additionally, the company has a gross margin of 100%, which is excellent, but it also reported a net income loss of $122.68 million in Q2 2026, indicating ongoing financial struggles. The main risk is the declining stock price, which has fallen 11.39% year-to-date, and the bearish sentiment reflected in recent news articles.

Beam Therapeutics Inc. (BEAM) last closed at $23.7900009, losing -1.08%. These facts feed the 1-day and 1-week BEAM price prediction above.